Maze Therapeutics, Inc.
MAZENASDAQHealthcareBiotechnology
As of Oct 27, 2026 close
- Market cap
- $1.87B
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $21.95$53.65
- Volume (live)
- -
- Avg. volume (3M)
- 929.47K
Maze Therapeutics (MAZE) Stock Price & Financial Analysis
Maze Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $30.88 - $32.01 |
|---|---|
| 52-Week High | $53.65 |
| 52-Week Low | $21.95 |
| Open | $31.18 |
| Volume (last close) | 624.99K |
| Average Volume (3M) | 929.47K |
| Revenue (TTM) | 20.00M |
|---|---|
| Net Income (TTM) | -133.59M |
| Free Cash Flow (TTM) | -106.84M |
| EPS (TTM) | −$2.52 |
| Profit Margin | -667.95% |
| Operating Margin | -728.06% |
| Return on Equity (ROE) | -29.48% |
| Debt to Equity | 0.10 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
| Market Cap | 1.87B |
|---|---|
| Shares Outstanding | 59.00M |
| Price to Sales (P/S) | 93.48 |
| Price to Book (P/B) | 4.13 |
| EV/EBITDA | -12.63 |
| 50-Day MA | $26.93 |
|---|---|
| 200-Day MA | $32.18 |
| 1-Year Change | +6.86% |
Source: Market prices and company fundamentals. Data as of Oct 27, 2026. Data sources and methodology
Maze Therapeutics at a Glance
As of the Oct 27, 2026 close, Maze Therapeutics (MAZE) has a market capitalization of $1.87B. The stock trades at 93.5× sales. Over the trailing twelve months it lost $133.59M on revenue of $20.00M and burned $106.84M of free cash flow. Revenue grew 700.0% year over year.
As of its latest reported balance sheet, it holds $202.64M in cash and securities against $43.84M of debt, a net cash position of $158.80M.
Maze Therapeutics does not currently pay a dividend.
The share price is up 6.9% over the past year. At $31.69 (the Oct 27, 2026 close) it sits within its 52-week range of $21.95 to $53.65, below its 200-day moving average of $32.18.
Based on 9 professional analyst ratings from the past 90 days, the consensus is Buy with an average price target of $63.13, 99.2% above the Oct 27, 2026 close.
Frequently Asked Questions About Maze Therapeutics
What is the current stock price for MAZE?
As of the Oct 27, 2026 close, MAZE stock trades at $31.69. The 52-week range is $21.95–$53.65, with a day range of $30.88–$32.01.
What is the P/E ratio for MAZE?
The P/E ratio (Price-to-Earnings) for MAZE is shown in the Key Statistics section. This valuation metric helps compare Maze Therapeutics, Inc. to industry peers.
Does MAZE pay dividends?
Maze Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for MAZE?
Based on ratings from 9 professional analysts over the last 90 days, the consensus for MAZE is Buy. The average 12-month price target is $63.13, a 99.2% upside from the Oct 27, 2026 close of $31.69.
What is the market cap of MAZE?
As of the Oct 27, 2026 close, Maze Therapeutics's market capitalization is $1.87B, classifying it as a small-cap company. Maze Therapeutics operates in the Healthcare sector within the Biotechnology industry.